Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

High-dose centanafadine was well-tolerated and outperformed placebo in improving ADHD symptoms among children and adolescents with ADHD.

NAC reduced CRP and IL-8 in a dose-dependent manner, which was associated with a beneficial effect on clinical and functional outcomes. The data presented here do not allow us to ascertain whether ...